ArticleFrontiers in neurology2021

Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.